on 27 Dec 2024
Last Applicant/ Owned by
Lyell Immunopharma, Inc.
201 Haskins WaySouth San Francisco, CA 94080
US
Serial Number
2144175 filed on 1st Nov 2021
Registration Number
TMA1278699 registered on 27th Dec 2024
Registration expiry Date
27th Dec 2034Correspondent Address
GOWLING WLG (CANADA) LLP
SUITE 2600, 160 ELGIN STREETOTTAWA
ONTARIO
CA
K1P1C3
Trademark usage description
pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, and infectious diseases, namely, respiratory infections, eye Read MoreVienna Information
26 . 1 . 1
CirclesCercles
26 . 1 . 5
More than two circles or ellipses, inside one another, spiralsPlus de deux cercles ou ellipses, les uns dans les autres, spirales
26 . 1 . 6
Several circles or ellipses, juxtaposed, tangential or intersectingPlusieurs cercles ou ellipses, juxtaposés, tangents ou se coupant
26 . 1 . 18
Circles or ellipses containing one or more lettersCercles ou ellipses contenant une ou plusieurs lettres
26 . 1 . 19
Circles or ellipses with inscriptions projecting beyond the circumferenceCercles ou ellipses avec inscriptions débordant la circonférence
26 . 1 . 26
Circles or ellipses with cutout areasCercles ou ellipses avec des zones découpées
27 . 5 . 1
Letters presenting a special form of writingLettres présentant un graphisme spécial
27 . 5 . 8
Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.
11
11
11
11
2144175
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 42 on 9th Oct 2024 | Advertised |
Submitted for opposition 26 on 16th Sept 2024 | Approved |
Submitted for opposition 27 on 16th Sept 2024 | Approval Notice Sent |
Submitted for opposition 22 on 22nd Feb 2024 | Search Recorded |
Submitted for opposition 20 on 22nd Feb 2024 | Examiner's First Report |
Submitted for opposition 287 on 17th May 2022 | Pre-Assessment Letter Sent |
Submitted for opposition 135 on 2th May 2022 | Amendment to Application |
Submitted for opposition 30 on 1st Nov 2021 | Filed |
Submitted for opposition 1 on 1st Nov 2021 | Created |
Submitted for opposition 31 on 1st Nov 2021 | Formalized |